Blood group incompatibilities in pregnancy

Area of Science:

• Immunology
• Obstetrics
• Pediatrics

Background:

• Hemolytic disease of the newborn results from maternal antibodies attacking fetal red blood cells.
• This antigen-antibody reaction causes fetal red blood cell destruction.
• Rh incompatibility, a common cause, is now largely preventable.

Purpose of the Study:

• To outline a management plan for hemolytic disease of the newborn.
• To address prevention and minimization of the disease's effects.
• To highlight challenges in antenatal ABO compatibility evaluation.

Main Methods:

• Review of existing knowledge on hemolytic disease.
• Prescription of a management strategy.
• Discussion of laboratory and personnel requirements.

Main Results:

• Rh incompatibility is preventable, but other blood groups remain a concern.
• Effective management requires organized medical resources.
• Antenatal evaluation of ABO compatibility is currently limited.

Conclusions:

• Despite advances, hemolytic disease of the newborn caused by non-Rh factors requires proactive management.
• Comprehensive planning involving medical staff and laboratory services is crucial.
• Further research into antenatal ABO compatibility testing is needed.